1 |
Ramus SJ, Forrest SM, Pitt DD, Cotton RG. Genotype and intellectual phenotype in untreated phenylketonuria patients. Pediatr Res 1999;45;474-81.
DOI
ScienceOn
|
2 |
Koch R, Moats R, GuttIer F, Guldberg P, Nelson M Jr. Blood-brain phenylalanine relationships in persons with phenylketonuria. Pediatrics 2000;106:1093-6.
DOI
ScienceOn
|
3 |
Gizewska M, Cabalska B, Cyrytowski L, Nowacki P, Zekanowski C, Walczak M, et al. Different presentations of late-detected phenylketonuria in two brothers with the same R408WJRlllX genotype in the PAR gene, J Intellect Disabil Res 2003;47:146-52.
DOI
ScienceOn
|
4 |
Scriver CR Why mutation analysis does not always predict clinical consequences: explanations in the era of genornics. J Pediatr 2002:140:502-6.
DOI
ScienceOn
|
5 |
Dipple KM, McCabe ER Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics, Am J Hurn Genet 2000; 66:1729-35.
DOI
ScienceOn
|
6 |
Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, et al. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria, J Clin Invest 1999:103:1169-78.
DOI
ScienceOn
|
7 |
Guttler F, Guldberg P, Mutation analysis anticipates dietary requirements in phenylketonuria. Eur J Pediatr 2000;159 Suppl 2:S150-3.
DOI
|
8 |
Kayaalp E, Treacy E, Waters PJ, Byck S, Nowacki P, Scriver CR Human phenylalanine hydroxylase mutations and hyperphenylalaninernia phenotypes: a rnetanalysis of genotype-phenotype correlations, Am J Hum Genet 1997;61: 1309-17.
DOI
ScienceOn
|
9 |
Moats RA, Koch R, Moseley K, Guldberg P, GuttIer F, Boles RG, et al. Brain phenylalanine concentration in the management of adults with phenylketonuria. J Inherit Metab Dis 2000;23:7-14.
DOI
ScienceOn
|
10 |
Eisensrnith RC, Woo SL. Population genetics of phenylke-tonuria. Acta Paediatr Suppl 1994;407:19-26.
|
11 |
Crome L. The association of phenylketonuria with leucodystrophy, J Neurol Neurosurg Psychiatry 1962;25:149-53.
DOI
|
12 |
Levy HL, Lobbregt D, Barnes PD, Poussaint TY. Maternal phenylketonuria: magnetic resonance imaging of the brain in offspring, J Pediatr 1996;128:770-5.
DOI
ScienceOn
|
13 |
Huether G, Kaus R, Neuhoff V. Brain development in experimental hyperphenylalaninernia: myelination, Neuropediatrics 1982:13:177-82.
DOI
|
14 |
Scriver CR, Kaufman S. Hyperphenylalaninernia; Phenyla-lanine hydroxylase deficiency. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001:1667-1724.
|
15 |
Phenylalanine hydroxylase locus database (http://www.pahdb. rncgill.ca).
|
16 |
Guldberg P, Rey F, Zschocke J, Romano V, Francois B, Michiels L, et al. A European multicenter study of phenyla-lanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 1998;63:71-9.
DOI
ScienceOn
|
17 |
Huttenlocher PR The neuropathology of phenylketonuria: human and animal studies, Eur J Pediatr 2000;159(Suppl 2):S102-6.
DOI
|
18 |
Moller HE, Weglage J, Bick U, Wiedermann D, Feldmann R, Ullrich K. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria. Pediatrics 2003;112:1580-3.
|
19 |
Lee DH, Koo SK, Lee K5, Yeon YJ, Oh HJ, Kim SW, et al. The molecular basis of phenylketonuria in Korean stational Analysis. J Hum Genet 2004;49:617-21.
DOI
|
20 |
Malamud N, Neuropathology of phenylketonuria, J Neuropathol Exp Neurol 1966:25:254-68.
DOI
|